Market Overview:
The global neurostimulation devices market reached a value of US$
7.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$
13.4 Billion by 2027, exhibiting a CAGR of
12.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different
end use sectors. These insights are included in the report as a major market contributor.
A neurostimulation device is a programmable medical transmitter that can deliver electrical signals to the specific parts of the human brain. It is also used to stimulate, inhibit, modify, regulate and alter the activity of the autonomous, central and peripheral nervous systems in the patient’s body. This primarily aids in the treatment of various medical ailments, such as movement disorders, chronic pain and epilepsy. It is also utilized in the operation of neural prosthetics, hearing aids, artificial vision, artificial limbs and brain-machine interfaces. Neurostimulation devices can be both implantable or externally placed.
The rising instances of neurological and lifestyle-related disorders, along with the rapidly growing geriatric population across the globe, are among the key factors driving the growth of the market. Furthermore, the increasing preference for minimally invasive (MI) procedures among patients is also providing a boost to the market growth. For instance, deep brain stimulation (DBS) is an MI procedure that uses neurostimulation devices to deliver electrical signals to a specific spot in the brain circuits. This aids in treating various degenerative disorders, such as Parkinson’s and Alzheimer’s disease. Additionally, technological advancements, including the development of devices that can electronically stimulate the nervous system to restore vision and regain post-paralysis motor movements, are creating a positive outlook for the market. Other factors, including significant growth in the medical industry, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurostimulation devices market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on stimulation type, device type, application and end-user.
Breakup by Stimulation Type:
- Internal Stimulation
- External Stimulation
Breakup by Device Type:
- SCS (Spinal Cord Stimulation) Devices
- DBS (Deep Brain Stimulation) Devices
- SNS (Sacral Nerve Stimulation) Devices
- VNS (Vagus Nerve Stimulation) Devices
- GES (Gastric Electrical Stimulation) Devices
- Transcutaneous Electrical Nerve Stimulation Devices
- Transcranial Magnetic Stimulation Devices
- Others
Breakup by Application:
- Pain Management
- Epilepsy
- Essential Tremors
- Urinary and Fecal Incontinence
- Depression
- Dystonia
- Parkinson’s Disease
- Others
Breakup by End-User:
- Rehabilitation Centers
- Hospitals
- Medical Clinics
- Others
Breakup by Region:
- North America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Biocontrol Medical, Boston Scientific Corporation, Cyberonics Inc., Medtronic Inc., Neuronetics Inc., Neuropace Inc., Neurosigma Inc., Nevro Corporation, ST. Jude Medical Inc., Synapse Biomedical Inc., etc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Stimulation Type, Device Type, Application, End-User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Biocontrol Medical, Boston Scientific Corporation, Cyberonics Inc., Medtronic Inc., Neuronetics Inc., Neuropace Inc., Neurosigma Inc., Nevro Corporation, ST. Jude Medical Inc. and Synapse Biomedical Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global neurostimulation devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global neurostimulation devices market?
- What is the breakup of the market based on the stimulation type?
- What is the breakup of the market based on the device type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the global neurostimulation devices market and who are the key players?
- What is the degree of competition in the market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neurostimulation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Stimulation Type
6.1 Internal Stimulation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 External Stimulation
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Device Type
7.1 SCS (Spinal Cord Stimulation) Devices
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 DBS (Deep Brain Stimulation) Devices
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 SNS (Sacral Nerve Stimulation) Devices
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 VNS (Vagus Nerve Stimulation) Devices
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 GES (Gastric Electrical Stimulation) Devices
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Transcutaneous Electrical Nerve Stimulation Devices
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Transcranial Magnetic Stimulation Devices
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Others
7.8.1 Market Trends
7.8.2 Market Forecast
8 Market Breakup by Application
8.1 Pain Management
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Epilepsy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Essential Tremors
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Urinary and Fecal Incontinence
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Depression
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Dystonia
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Parkinson’s Disease
8.7.1 Market Trends
8.7.2 Market Forecast
8.8 Others
8.8.1 Market Trends
8.8.2 Market Forecast
9 Market Breakup by End-User
9.1 Rehabilitation Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Medical Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 France
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 United Kingdom
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 Italy
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Spain
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Russia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 Japan
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 India
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 South Korea
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Australia
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Indonesia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
12.1 Overview
12.2 Inbound Logistics
12.3 Operations
12.4 Outbound Logistics
12.5 Marketing and Sales
12.6 Post Sales Services
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biocontrol Medical
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Boston Scientific Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Cyberonics Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Medtronic Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Neuronetics Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Neuropace Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Neurosigma Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Nevro Corporation
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 ST. Jude Medical Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Synapse Biomedical Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
List of Figures
Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2021
Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2021
Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2021
Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2021
Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2021
Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Neurostimulation Devices (Parkinson’s Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Neurostimulation Devices (Parkinson’s Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Global: Neurostimulation Devices Industry: SWOT Analysis
Figure 102: Global: Neurostimulation Devices Industry: Value Chain Analysis
Figure 103: Global: Neurostimulation Devices Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million US$), 2022-2027
Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million US$), 2022-2027
Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Neurostimulation Devices Market: Competitive Structure
Table 8: Global: Neurostimulation Devices Market: Key Players